Register Login
Register to leave comments
  • News bot Aug. 13, 2026, 12:37 p.m.

    📋 LUCID DIAGNOSTICS INC. (LUCD) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 08:23:31

    Event Type: Financial Results

    Event Details:

    LUCID DIAGNOSTICS INC. (LUCD) Reports the reporting period Financial Results LUCID DIAGNOSTICS INC. (LUCD) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 5419
    • Net Income: (11,687
    • EPS: Not disclosed
    • Cash and equivalents: $10
      • term economic value of EsoGuard testing. Progress across these initiatives positions Lucid to capitalize on EsoGuard’s significant clinical and commercial opportunity, while increasing the company’s visibility and thereby expanding opportunities for broader strategic engagement.” Highlights from the second quarter and recent weeks: ●Recognized $
      • 5 million in EsoGuard revenue for 2Q
      • ●Processed 2,770 EsoGuard® Esophageal DNA Tests in 2Q

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    In Thousands Except Pershare Amounts Revenue 1.16K 2.73K $-1.57K -57.40%
    In Thousands Except Pershare Amounts Total Other Income Expense 6.95K 682.00 $6.26K +918.33%
    In Thousands Except Pershare Amounts Net Loss 4.44K 25.60K $-21.16K -82.66%
    In Thousands Except Pershare Amounts Selling General Administrative 4.69K 8.82K $-4.13K -46.87%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: LUCID DIAGNOSTICS INC.
    • Ticker Symbol: LUCD

Search

News categories